Electrolytic detachment for implantable devices

Information

  • Patent Grant
  • 10828039
  • Patent Number
    10,828,039
  • Date Filed
    Thursday, June 8, 2017
    6 years ago
  • Date Issued
    Tuesday, November 10, 2020
    3 years ago
Abstract
Delivery and detachment of an implant can be enhanced by a retraction mechanism to secure portions of a delivery wire within an interior space of the implant. A delivery system can include an implant having a proximal end portion. A delivery wire can include (i) a detachment zone proximal to the proximal end portion and (ii) a distal region distal to the proximal end portion. An expansion member can be located between the proximal end portion and the distal region of the delivery wire. The expansion member can be biased to move the distal region of the delivery wire distally away from the proximal end portion when severed at the detachment zone.
Description
FIELD

The subject technology relates to the delivery of implantable medical devices and systems for delivering implantable medical devices.


BACKGROUND

The use of endovascular techniques for the implantation of medical devices for treatment, e.g., by occlusion, of body cavities such as arteries, veins, fallopian tubes or vascular deformities is known in the art. For example, vascular aneurysms can be occluded with an implant that is introduced with a delivery wire through a catheter. Once advanced to the treatment site, the implant is inserted into the aneurysm cavity to occlude the aneurysm and then detached from the delivery wire.


SUMMARY

Electrolytic detachment of an implant from a delivery system can leave a portion of a delivery wire protruding from the implant after detachment, presenting a risk of harm to the surrounding anatomy. An implant can be attached to a delivery wire in a manner that minimizes an extent to which a distal region of the delivery wire protrudes from the implant after the implant is detached from a proximal region of the delivery wire. For example, an implant can be connected to a distal end of a delivery wire such that a severed distal portion of the delivery wire is retracted into an interior space of the implant upon severance of the implant from the proximal region of the delivery wire. Such an arrangement advantageously can reduce the extent of protrusion compared to an attachment that does not provide retraction capability.


The subject technology is illustrated, for example, according to various aspects described below. Various examples of aspects of the subject technology are described as numbered clauses (1, 2, 3, etc.) for convenience. These are provided as examples and do not limit the subject technology.


Clause 1. An implant comprising:

    • a proximal end portion defining a lumen; and
    • an expansion member located distal to the proximal end portion and proximal to a distal region of a delivery wire, the distal region being distal to the proximal end portion, the expansion member being biased to move the distal region of the delivery wire distally away from the proximal end portion;
    • wherein at least a portion of the delivery wire extends entirely through the lumen.


Clause 2. The implant of clause 1, wherein the expansion member comprises a spring.


Clause 3. The implant of any of the previous clauses, wherein a distal cross-sectional dimension of the distal region is greater than a lumen cross-sectional dimension of the lumen.


Clause 4. The implant of any of the previous clauses, wherein the distal region of the delivery wire comprises an electrolytically corrodible section.


Clause 5. The implant of any of the previous clauses, wherein the delivery wire comprises a detachment zone proximal to the proximal end portion.


Clause 6. The implant of clause 5, wherein a distal cross-sectional dimension of the distal region is greater than a proximal cross-sectional dimension of the detachment zone.


Clause 7. The implant of clause 5, further comprising a coating layer that electrically insulates the detachment zone of the delivery wire from the proximal end portion.


Clause8. A delivery system comprising:

    • an implant having a proximal end portion;
    • a delivery wire having (i) a detachment zone proximal to the proximal end portion, and (ii) a distal region distal to the proximal end portion;
    • an expansion member located between the proximal end portion and the distal region of the delivery wire, the expansion member being biased to move the distal region of the delivery wire distally away from the proximal end portion; and
    • a catheter, wherein at least a portion of the delivery wire is within the catheter.


Clause 9. The implant of clause 8, wherein the expansion member comprises a spring.


Clause 10. The implant of any of clauses 8-9, wherein the proximal end portion defines a lumen, and at least a portion of the delivery wire extends entirely through the lumen.


Clause 11. The implant of any of clauses 8-10, wherein a distal cross-sectional dimension of the distal region is greater than a lumen cross-sectional dimension of the lumen.


Clause 12. The implant of any of clauses 8-11, wherein the distal region of the delivery wire comprises an electrolytically corrodible section.


Clause 13. The implant of an of clauses 8-12, wherein a distal cross-sectional dimension of the distal region is greater than a proximal cross-sectional dimension of the detachment zone.


Clause 14. The implant of any of clauses 8-13, further comprising a coating layer that electrically insulates the detachment zone of the delivery wire from the proximal end portion.


Clause 15. A method of delivering an implant, the method comprising:

    • positioning the implant at a target location within a patient, the implant being attached to a delivery wire having (i) a proximal region, (ii) a detachment zone proximal to a proximal end portion of the implant, and (iii) a distal region distal to the proximal end portion, the implant having an expansion member located between the proximal end portion and a distal region of the delivery wire, the expansion member being biased to move the distal region of the delivery wire distally away from the proximal end portion;
    • separating the distal region from the proximal region at the detachment zone; and
    • advancing the distal region distally away from the proximal end portion.


Clause 16. The method of clause 15, wherein separating the implant comprises electrolytically corroding a portion of the delivery wire.


Clause 17. The method of an of clauses 15-16, wherein positioning the implant comprises applying a distally directed force to the proximal end portion and a proximally directed force to the delivery wire.


Clause 18. The method of any of clauses 15-17, wherein applying a distally directed force to the proximal end portion comprises pushing the proximal end portion with a catheter.


Clause 19. The method of any of clauses 15-18, wherein at least a portion of the delivery wire is within the catheter during the separating.


Clause 20. The method of any of clauses 15-19, wherein the advancing the distal region comprises advancing the detachment zone and the distal region of the delivery wire to be entirely distal to a proximal end of the proximal end portion.


Additional features and advantages of the subject technology will be set forth in the description below, and in part will be apparent from the description, or may be learned by practice of the subject technology. The advantages of the subject technology will be realized and attained by the structure particularly pointed out in the written description and claims hereof as well as the appended drawings.


It is to be understood that both the foregoing general description and the following detailed description are exemplifying and explanatory and are intended to provide further explanation of the subject technology as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings, which are included to provide further understanding of the subject technology and are incorporated in and constitute a part of this description, illustrate aspects of the subject technology and, together with the specification, serve to explain principles of the subject technology.



FIG. 1A shows a perspective view of a delivery system, in accordance with one or more embodiments of the present disclosure.



FIG. 1B shows a perspective view of the delivery system of FIG. 1A with respect to a patient, in accordance with one or more embodiments of the present disclosure.



FIG. 2 shows a side view of a braid ball implant, in accordance with one or more embodiments of the present disclosure.



FIG. 3 shows a sectional view of the braid ball implant of FIG. 2 deployed within a bifurcation aneurysm, in accordance with one or more embodiments of the present disclosure.



FIG. 4A shows a side view of a distal end of the delivery system of FIG. 1, in accordance with one or more embodiments of the present disclosure.



FIG. 4B shows a sectional view of the distal end of the delivery system shown in FIG. 4A in an attached state, in accordance with one or more embodiments of the present disclosure.



FIG. 5 shows a sectional view of the distal end of the delivery system shown in FIG. 4A in a detached state, in accordance with one or more embodiments of the present disclosure.



FIG. 6 shows a sectional view of a distal end of a delivery system, similar in some respects to the delivery system of FIGS. 4A and 4B, in an attached state, in accordance with one or more embodiments of the present disclosure.



FIG. 7 shows a sectional view of the distal end of the delivery system shown in FIG. 6 in a detached state, in accordance with one or more embodiments of the present disclosure.



FIG. 8 shows a partial sectional view of an implant in a stage of deployment, in accordance with one or more embodiments of the present disclosure.



FIG. 9 shows a partial sectional view of an implant in a stage of deployment, in accordance with one or more embodiments of the present disclosure.



FIG. 10 shows a partial sectional view of an implant in a stage of deployment, in accordance with one or more embodiments of the present disclosure.





DETAILED DESCRIPTION

In the following detailed description, specific details are set forth to provide an understanding of the subject technology. It will be apparent, however, to one ordinarily skilled in the art that the subject technology may be practiced without some of these specific details. In other instances, well-known structures and techniques have not been shown in detail so as not to obscure the subject technology.


In accordance with some embodiments of the subject technology an implant can be attached to a delivery wire in a manner that minimizes an extent to which a distal region of the delivery wire protrudes from the implant after the implant is detached from a proximal region of the delivery wire. For example, an implant can be connected to a distal end of a delivery wire such that a severed distal region of the delivery wire is retracted into an interior space of the implant upon severance of the implant from the proximal region of the delivery wire. Such an arrangement advantageously can reduce the extent of protrusion compared to an attachment that does not provide retraction capability.


Referring to FIGS. 1A-B, illustrated are various views of a delivery system 10, according to one or more embodiments of the subject technology. More particularly, FIG. 1A depicts a view of a delivery system 10, and FIG. 1B depicts a view of the same delivery system in connection with a patient. According to some embodiments, a delivery system 10 can include an implant 20, and a delivery catheter 100 connected to a handle 48. The handle 48 shown provides proximal access to a delivery wire 44 that is connected to the implant 20 at a distal end thereof. The implant 20, attached to the distal end of the delivery wire 44, is advanced in the longitudinal direction in the delivery catheter 100 to the treatment site. Common treatment sites include blood vessels, particularly those in the neurovasculature such as aneurysms.


According to some embodiments, for example as shown in FIGS. 1A-B, the delivery catheter 100 can be formed as a generally tubular member with a body extending from a proximal end 110 and terminating in a distal end 112. Several commercially available microcatheter designs are suitable for the use in the disclosed embodiments. A microcatheter suitable for neurovascular use has a length that is at least 125 cm long, and more particularly may be between about 125 cm and about 175 cm long. Typically the delivery catheter 100 is about 155 cm long. An inner lumen of the delivery catheter 100 generally has an inner diameter between about 0.01 inch and about 0.098 inch (0.25-2.49 mm). Other designs and dimensions are contemplated. Commercially available microcatheters which may be suitable for use as delivery catheters include the REBAR™ Reinforced Micro Catheter and the MARKSMAN™ Catheter, both of which are available from Medtronic Inc. (Irvine, Calif.).


A power supply 46 can be coupled to the delivery system 10. A current can flow from the power supply 46 along a delivery wire 44 to a detachment zone 30. The detachment zone 30 can comprise a longitudinally extending zone within which some or all of an electrolytically corrodible portion of the delivery wire 44 can be positioned, as discussed further herein. The detachment zone 30 can be between a portion of the delivery wire 44 and the implant 20. The current can flow from the detachment zone 30 to a return path, optionally via a structure extending near the detachment zone 30. For example, the power supply 46 can be coupled to a portion of the delivery wire 44 extending proximally of the handle 48, and the delivery wire 44 can conduct the electrically current to or from the detachment zone 30. Alternatively or in combination, the power supply 46 also can be coupled to, and electrical current can be conducted by, the delivery wire 44, the handle 48, the delivery catheter 100, the fluid source 150, and/or the patient via a region 47 on the surface of the patient's skin to provide a conductive pathway between the detachment zone 30 and the power supply 46 or ground. For example, a positive terminal of a direct current power supply 46, for example as shown in FIG. 1A, may be coupled to the portion of the delivery wire 44 extending proximally of the handle 48, and a negative terminal of a direct current power supply 46 or ground may be coupled to the handle 48, the delivery catheter 100, the fluid source 150, and/or the patient via the region 47. In embodiments wherein the delivery wire 44, the handle 48, and/or the delivery catheter 100 are attached, directly or indirectly, to the power supply 46 or ground to conduct electrical current, they can comprise electrically conductive materials and/or components for conduction of electrical current between the detachment zone and the power supply or ground. Similarly, in embodiments wherein fluid conducts electrical current between the detachment zone and the power supply or ground, the fluid source 150 can comprise an electrically conductive fluid.


According to some embodiments, the power supply 46 can include an electrical generator configured to output an electrical current that is sufficient to detach the implant 20 by electrolytic corrosion. The power supply 46 may be a direct current power supply, an alternating current power supply, or a power supply switchable between a direct current and an alternating current. The power supply 46 can include a suitable controller that can be used to control various parameters of the energy output by the generator, such as intensity, amplitude, duration, frequency, duty cycle, and polarity. For example, the power supply 46 can provide a voltage of about 12 volts to about 28 volts and a current of about 1 mA to about 2 mA.


According to some embodiments, for example as shown in FIG. 1A, a fluid source 150 may be provided in connection with a pump 162 for infusion of the fluid 170 via the delivery catheter 100. The fluid source 150 can be saline or another sterile, electrolytic, biocompatible solution. The fluid can be infused together with a drug such as heparin. The fluid may be drawn from the fluid source 150 into the pump 162 and provided to a lumen of the delivery catheter 100. The pump 162 can be an infusion pump, a pressurized container, and/or a gravity-based infusion mechanism. According to some embodiments, for example as shown in FIGS. 1A and 1B, current can be provided from the power supply 46 via the delivery wire 44 to the detachment zone 30, as discussed in more detail below. While the implant 20 and the detachment zone 30 are within the patient, the current from the detachment zone 30 may flow through tissue of the patient until the current reaches a terminal of the power supply 46 that is connected to the patient at a region 47. For example, the terminal (e.g, a needle) at the region 47 can be placed on or through the surface of the patient's skin to provide a conductive pathway from the detachment zone 30 at or near the implant 20 to ground or to the power supply 46.


According to some embodiments, for example as shown in FIGS. 2 and 3, an implant 20 delivered by the delivery system 10 can be a braid ball implant. The implant 20 can be formed from tubular braid stock including a resilient material, such as nitinol, that defines an open volume in an uncompressed/unconstrained state. The size of the implant can be selected to fill an aneurysm 2. The implant 20 can include a hub 50 at a proximal end 53 thereof. The hub 50 can be fixedly attached to the remainder of the implant 20. The implant 20 can include layers 26, 28 at least where impacted by flow at the neck 9 of the aneurysm 2.


According to some embodiments, the implant 20 can be placed within an aneurysm 2 at a vascular bifurcation 4, formed by trunk vessel 6 and branch vessels 8, for example as illustrated in FIG. 3. The implant 20 can be delivered by access through the trunk vessel 6 (e.g., the basilar artery), preferably through a commercially available microcatheter with a delivery system as detailed below. To deliver the implant 20, the delivery wire 44 is positioned such that the implant 20 can be delivered at least partially into the aneurysm 2. When the implant is positioned in the aneurysm, the implant 20 is separated from a proximal portion of the delivery wire 44 by electrolytic corrosion, and a distal portion of the delivery wire 44 is withdrawn into the delivery catheter 100.


While the implant 20 illustrated herein is a braided ball, the implant 20 can be any well-known treatment device including, but not limited to, a vasoocclusive coil, a stents, filters, or flow diverters.



FIGS. 4A-5 illustrate various views of a delivery wire 44 and implant 20 according to one or more embodiments of the subject technology. More particularly, FIG. 4A depicts a side view of the delivery wire 44 and implant 20, FIG. 4B depicts a sectional view of the delivery wire 44 and implant 20 in an attached state, and FIG. 5 depicts a sectional view of the delivery wire 44 and implant 20 in a detached state. Upon separation of a proximal portion of the delivery wire 44 from the implant 20, a spring force from a compression spring and applied to the distal portion of the delivery wire 44 can retract the distal portion of the delivery wire 44 into the implant 20 as described further herein. As a result, the distal portion of the delivery wire 44 is retained securely within the implant 20. The extent to which the delivery wire 44 protrudes proximally of the implant 20 is thereby reduced when compared to an arrangement that does not achieve such retraction.


According to some embodiments, for example as shown in FIGS. 4A-4B, the delivery wire 44 (e.g., core member, pusher device, etc.) has a proximal region 40, a distal region 42, and a detachment zone 30 between the proximal region 40 and the distal region 42. The delivery wire 44 can be formed of a single, monolithic component that spans across the proximal region 40, the distal region 42, and the detachment zone 30. Alternatively, the delivery wire 44 can be formed of separate segments that are joined together at any location thereon.


According to some embodiments, portions of the delivery wire 44 can be coated with a nonconductive material so that only a limited portion of surface area of the delivery wire is exposed to, and in electrical communication with, the electrolyte for corrosion when a voltage potential is applied. Limiting the size of the exposed portion of the surface area of the delivery wire can concentrate electrolytic activity to expedite corrosion through and severance of the delivery wire. A proximal insulating layer 34 can be provided over at least a portion of an outer surface of the proximal region 40. For example, the proximal insulating layer 34 can circumferentially surround an outer surface of the proximal region 40 extending proximally from a proximal end of the detachment zone 30 to a location at or near a proximal end of the delivery wire 44. Similarly, a distal insulating layer 32 can be provided over at least a portion of an outer surface of the distal region 42 extending distally from a distal end of the detachment zone 30 to a distal terminal end of the delivery wire 44. For example, the distal insulating layer 32 can circumferentially surround and cover the entire outer surface of the distal region 42.


According to some embodiments, proximal and distal insulating layers 34, 32 leave exposed the detachment zone 30 between the proximal region 40 and the distal region 42. When in contact with a body fluid, such as blood, the fluid serves as an electrolyte allowing current to be focused on the non-coated detachment zone 30. The proximal and distal insulating layers 34, 32 prevent exposure of the proximal region 40 and the distal region 42 to the fluid. Accordingly, electrical energy conducted along the delivery wire 44 is concentrated at the detachment zone 30, thereby reducing the time required to erode away the detachment zone 30. The proximal and distal insulating layers 34, 32 can be over-molded, co-extruded, sprayed on, or dip-coated with respect to the proximal region 40 and/or the distal region 42.


The distal insulating layer 32 also prevents electrical connection between the delivery wire 44 and the implant 20. As shown in FIGS. 4A-4B, the distal insulating layer 32 electrically isolates the implant 20 from an electrical current conducted along a length of the delivery wire 44, from the proximal region 40 and the distal region 42. A proximal end of the distal insulating layer 32 may be positioned at or proximal to the hub 50, and a distal end of the distal insulating layer 32 may be positioned at or distal to the hub 50. Likewise, a proximal end of the distal region 42 may be positioned proximal to the hub 50, and a distal end of the distal region 42 may be positioned within or distal to the hub 50. The distal insulating layer 32 insulates the distal region 42 from the hub 50 to prevent the electrical current from being conducted to the implant 20.


The proximal and distal insulating layers 34, 32 can be of an electrically nonconductive or insulative polymer, such as polyimide, polypropylene, polyolefins, and combinations thereof. In some embodiments, the proximal and distal insulating layers 34, 32 can be applied as a single coating with a portion thereof subsequently removed to expose the detachment zone 30. Laser ablation can be employed to selectively remove the coating to a controlled length, minimizing the time required to erode through the component. Lengths as small as 0.0005″ and as large as 0.1″ or longer can be removed. According to some embodiments, lengths of detachment zone 30 can be greater than 0.005″ and/or less than 0.010″ to provide sufficient exposure to achieve detachment times of less than 30 seconds.


The delivery wire 44 (including some or all of the proximal region 40, the distal region 42, or the detachment region 30) can comprise one or more of the following materials: ceramic materials, plastics, base metals or alloys thereof, or combinations thereof. Some of the most suitable material combinations for forming the electrolytically corrodible points can include one or more of the following: stainless steels, preferably of the type AISI 301, 304, 316, or subgroups thereof; Ti or TiNi alloys; Co-based alloys; noble metals; or noble metal alloys, such as Pt, Pt metals, Pt alloys, Au alloys, or Sn alloys. In some embodiments, the electrolytically corrodible detachment zone 30 can be pre-corroded by etching or other methods.


According to some embodiments, for example as shown in FIG. 4B, the delivery wire 44 can be continuous at least through the proximal region 40. Accordingly, an electrical potential can be generated at the proximal end of the delivery wire 44 and an electrical current can be conducted through the delivery wire 44 between the proximal region 40 and the detachment zone 30. Furthermore, an axial force applied to the delivery wire 44 can result in an axial movement of the detachment zone 30 and/or the implant 20. Alternatively or in combination, axial forces can be applied to the implant 20 by other devices, such as the delivery catheter 100.


According to some embodiments, for example as shown in FIG. 4B, a proximal section 70 of the distal region 42 can extend through a lumen 52 of the hub 50. The proximal section 70 can have a proximal outer cross-sectional dimension 72 along at least the portions thereof within the hub 50 and extending proximally from the hub to the detachment zone 30. The proximal cross-sectional dimension 72 can be smaller than an inner cross-sectional dimension 54 of the lumen 52 within the hub 50. At least a portion of the proximal section 70 can freely move within the lumen 52 to provide axial (i.e., proximal and/or distal) mobility within the lumen 52.


According to some embodiments, a distal section 80 of the distal region 42 can be located distal to the hub 50 the distal section 80 can have a distal outer cross-sectional dimension 82 that is greater than the proximal outer cross-sectional dimension 72 and/or the inner cross-sectional dimension 54 of the lumen 52. The dimensions of the distal section 80 can prevent the distal section 80 and other sections attached thereto from moving entirely through the lumen 52 of the hub 50. Furthermore, the distal outer cross-sectional dimension 82 can be greater than any opening, aperture, interstice, port, or window separating the inner cavity 90 of the implant 20 from an external environment. Accordingly, once the implant 20 is fully formed, the distal section 80 and any components attached thereto can be prevented from moving entirely out of the inner cavity 90 of the implant 20.


According to some embodiments, an expansion member 60, or a portion thereof, can be located between at least a portion of the distal section 80 and at least a portion of the hub 50. The expansion member 60 can be or include a spring or other mechanism for providing elastic forces. For example, the spring can be a compression spring that responds to a compression load by shortening or reducing its length. The expansion member 60 can include a helical coil that has a spring constant. Alternatively or in combination, the expansion member 60 can be an axially and/or circumferentially continuous material (e.g., tube, strut, braid, etc.) with elastic properties. The expansion member 60 can store potential energy when placed in certain configurations to provide a bias toward a relaxed state. The bias may include a tendency to axially elongate after the expansion member 60 is axially compressed. Accordingly, the extension member 60 can be biased to move axially adjacent structures axially away from each other. For example, the expansion member 60 can be seated against and/or placed between the hub 50 and the distal section 80. The expansion member 60 can be axially compressed by moving the distal section 80 and the hub 50 toward each other. For example, the distal section 80 can be moved proximally relative to the hub 50 and/or the hub 50 can be move distally relative to the distal section 80. Axial forces can be applied to the distal section 80 by, for example, other portions of the delivery wire 44, such as the proximal region 40 of the delivery wire 44. Axial forces can be applied to the hub 50 by, for example, other devices, such as the delivery catheter 100, as discussed further herein.


According to some embodiments, for example as shown in FIG. 5, the proximal region 40 of the delivery wire 44 can be separated from the distal region 42 of the delivery wire 44 at the detachment zone 30. Separation at the detachment zone 30 can be achieved by electrolytic corrosion, mechanical release, chemical reactions, thermal activity, or combinations thereof. The result of the separation can include the complete separation of (a) the implant 20, including the hub 50, and the distal region 42 of the delivery wire 44, including the distal insulating layer 32, the proximal section 70, and the distal section 80, from (b) the proximal region 40 of the delivery wire 44, including the proximal insulating layer 34 and/or other components along the delivery wire 44. Portions of the detachment zone 30 that are not completely removed can remain attached to portions of the proximal region 40 and/or the distal region 42. For purposes of discussion herein, such remaining portions of the detachment zone 30 can be considered, after separation, components of the proximal region 40 and/or the distal region 42.


According to some embodiments, after separation at the detachment zone 30, the expansion member 60 can act on the hub 50 and the distal section 80 to achieve distally directed movement of the distal section 80 and/or the proximal section 70. After separation, the expansion member 60 can be permitted to freely expand to achieve a relaxed state. The distally directed movement of the distal section 80 and/or the proximal section 70 can continue until a proximalmost terminal end of the proximal section 70 is distal to a proximal most terminal end of the hub 50 and/or the lumen 52. The distally directed movement of the distal section 80 and/or the proximal section 70 can continue until a proximalmost terminal end of the proximal section 70 is entirely distal to the hub 50 and/or within the interior cavity 90 of the implant 20. According to some embodiments, the proximal section 70 and the distal section 80 can freely move within the cavity 90 of the implant 20 after separation. The dimensions of the distal section 80 and/or the proximal section 70 can exceed the dimensions of the lumen 52 and/or other openings between the cavity 90 in an external environment of the implant 20, such that the distal section 80 and the proximal section 70 are retained within the interior cavity 90 of the implant 20.



FIGS. 6 and 7 illustrate various views of an exemplifying delivery wire 44 and implant 20 according to one or more embodiments of the subject technology. More particularly, FIG. 6 depicts a sectional view of the delivery wire 44 and implant 20 in an attached configuration, and FIG. 7 depicts a sectional view of the delivery wire 44 and implant 20 in a detached configuration. Upon separation of a proximal portion of the delivery wire 44 from the implant 20, a spring force from a tension spring and applied to the distal portion of the delivery wire 44 can retract the distal portion of the delivery wire 44 into the implant 20 as described further herein. While FIGS. 4A-5 illustrate a delivery wire 44 and implant 20 with a compression spring, the delivery wire 44 and implant 20 can be used with a tension spring, for example as illustrated in part in FIGS. 6 and 7, according to one or more embodiments of the subject technology. Therefore, the delivery wire 44, the implant 20, and other elements and components are not described again in detail with reference to FIGS. 6-7, as these components can be readily understood from the other disclosure of them herein.


According to some embodiments, for example as shown in FIG. 6, the delivery wire 44 can provide a detachment zone 30 between the proximal insulating layer 34 and the distal insulating layer 32. According to some embodiments, for example as shown in FIG. 6, the proximal section 70 of the distal region 42 can extend through or near a lumen 52 of the hub 50. At least a portion of the proximal section 70 can freely move within the lumen 52 to provide axial (i.e., proximal and/or distal) mobility within the lumen 52.


According to some embodiments, the proximal section 70 can connect to one or more expansion members 160, or a portion thereof, can be located between at least a portion of the distal section 80 and at least a portion of the hub 50. The expansion member 160 can be or include a spring or other mechanism for providing elastic forces. For example, the spring can be a tension or extension spring that responds to a tension load by elongating or increasing its length. The expansion members 160 can include a helical coil that has a spring constant. Alternatively or in combination, the expansion member 160 can be an axially and/or circumferentially continuous material (e.g., tube, strut, braid, etc.) with elastic properties. A plurality of expansion members 160 can attach to various regions or the same region of the proximal section 70 and to various regions or the same region of the hub 50. For example, the expansion members 160 can attach to a distalmost terminal end region of the proximal section 70. The expansion members 160 can attach, for example, to the distal insulating layer 32, such that the distal region 42 is not in electrical connection with the expansion members 160. The expansion members 160 can further attached to a distalmost end region of the hub 50. The expansion members 160 can attach to the hub 50 at a variety of distributed locations along the circumference of the hub 50. According to some embodiments, for example as shown in FIG. 6, the expansion members 160 can extend within the lumen 52 of the hub 50 at least to a location distal to the hub 50 and/or within the cavity of the implant 20. The expansion members 160 can, from this location, extend proximally to the distalmost terminal end of the hub 50 attached thereto. The attachment of the expansion members 160 to the hub 50 can occur generally at the proximal end 53 of the implant 20, such that the expansion members 160 need not extend across an entire or substantial length of the implant 20. For example, the expansion members 160 can attach to the implant 20 at a proximal half of the implant 20.


The expansion member 160 can store potential energy when placed in certain configurations to provide a bias toward a relaxed state. The bias may include a tendency to axially shorten after the expansion members 160 are axially elongated. Accordingly, the expansion members 160 can be biased to move axially adjacent structures toward each other. For example, the expansion member 160 can be attached to the hub 50 and the proximal section 70. The expansion member 160 can be axially elongated by moving the proximal section 70 and the hub 50 away from each other. For example, the proximal section 70 can be moved proximally relative to the hub 50 and/or the hub 50 can be move distally relative to the proximal section 70. Axial forces can be applied to the proximal section 70 by, for example, other portions of the delivery wire 44, such as the proximal region 40 of the delivery wire 44. Axial forces can be applied to the hub 50 by, for example, other devices, such as the delivery catheter 100, as discussed further herein.


According to some embodiments, for example as shown in FIG. 7, the proximal region 40 of the delivery wire 44 can be separated from the distal region 42 of the delivery wire 44 along the detachment zone 30. According to some embodiments, after separation along the detachment zone 30, the expansion members 160 can act on the hub 50 and the proximal section 70 to achieve distally directed movement of the proximal section 70. After separation, the expansion members 160 can be permitted to freely shorten to achieve a relaxed state. The distally directed movement of the proximal section 70 can continue until a proximalmost terminal and of the proximal section 70 is distal to a proximal most terminal end of the hub 50 and/or the lumen 52. The distally directed movement of the proximal section 70 can continue until a proximalmost terminal end of the proximal section 70 is entirely distal to the hub 50 and/or within the interior cavity 90 of the implant 20. According to some embodiments, the proximal section 70 can remain attached to the hub 50 via the expansion members 160 after separation from the proximal region 40.



FIGS. 7-10 illustrate various stages of an exemplifying method according to one or more embodiments of the subject technology. More particularly, FIG. 8 illustrates an implant 20 connected to a delivery wire 44, FIG. 9 illustrates detachment in progress, and FIG. 10 illustrates a state following detachment of the implant 20 from the delivery wire 44.


According to some embodiments, the implant 20 can be advanced to the target site. As shown in FIG. 8, the delivery catheter 100 can be brought to the implant 20, such that the distal end 112 of the delivery catheter 100 can contact or otherwise act on the implant 20. For example, the distal end 112 can be used to apply a distally directed force to the hub 50 while a proximally directed force is applied to the delivery wire 44. Alternatively or in combination, one of the delivery wire 44 and the implant 20 can be stabilized while the other is subjected to a force. The relative forces applied to the delivery wire 44 and the implant 20 can cause the delivery wire 44 to be moved proximally relative to the implant 20. For example, the detachment zone 30 can be located outside and proximal to the hub 50 and/or other portions of the implant 20. The detachment zone 30 may be positioned to be entirely exposed, partially exposed, or not exposed with respect to the implant 20 and/or the hub 50. Alignment of the delivery catheter detachment zone 30 may be facilitated by components providing visualization. For example, a radiopaque marker of the implant 20 can be aligned with a radiopaque marker of the delivery wire 44 while in a configuration that corresponds to proper alignment (e.g., axial alignment).


According to some embodiments, for example as shown in FIG. 9, detachment of the implant 20 from the delivery wire 44 can be achieved through electrolytic corrosion of the detachment zone 30. An electrical potential can be provided by the power supply 46 to cause electrical current to pass between the detachment zone 30 and another region in the vicinity of the detachment region 30. For example, electrical current can pass between the fluid 170 and the detachment region 30. Fluids other than the fluid 170 from the fluid source 150 can also contribute to an electrical pathway. For example, blood from the body of the patient may mix with the fluid 170 and form a portion or the entirety of the pathway. According to some embodiments, for example as shown in FIG. 9, fluid flow 170 can be provided during electrolytic detachment of the implant 20 from the delivery wire 44. For example, an infusion of fluid from the fluid source 150 by the pump 162 can be provided via the lumen 124 of the delivery catheter 100 past the detachment region 30.


According to some embodiments, severance of the detachment zone 30 can be achieved by a variety of mechanisms. Separation along the detachment zone 30 can be achieved by electrolytic corrosion, mechanical release, chemical reactions, thermal activity, or combinations thereof. By any means, the result of the separation can include the complete separation of the implant 20 from at least a portion of the delivery wire 44.


According to some embodiments, for example as shown in FIG. 10, full separation along the detachment zone 30 results in the implant 20 being entirely separated from at least a portion of the delivery wire 44. The portions of the delivery wire 44 that were located on the implant side of the detachment zone 30 can be readily retracted into the hub 50 and/or the implant 20 as described herein. As a result, such portions (e.g., the distal region 42 of the delivery wire 44, the distal insulating layer 32, the proximal section 70, and/or the distal section 80) can be moved distally to be located entirely distal to the proximalmost terminal end of the implant 20 (e.g., the hub 50). Such portions can be retained securely within the implant. Thrombosis formation within the implant 20 (e.g., within the cavity 90) can further secure such portions within the implant 20. In the final configuration described above, the extent to which the delivery wire 44 protrudes proximally of the implant 20 is reduced when compared to a delivery wire that is fixed relative to an implant. Once the protruding end of the delivery wire 44 is retracted within the implant 20, the remaining outer periphery of the implant 20 can be atraumatic. The reduction or elimination of a protrusion beneficially reduces a risk that such a protruding end would damage surrounding tissue.


Upon detachment, the delivery wire 44 and the delivery catheter 100 can be retracted away from the target site and out of the patient, leaving the implant 20 at the target site.


The foregoing description is provided to enable a person skilled in the art to practice the various configurations described herein. While the subject technology has been particularly described with reference to the various figures and configurations, it should be understood that these are for illustration purposes only and should not be taken as limiting the scope of the subject technology.


There may be many other ways to implement the subject technology. Various functions and elements described herein may be partitioned differently from those shown without departing from the scope of the subject technology. Various modifications to these configurations will be readily apparent to those skilled in the art, and generic principles defined herein may be applied to other configurations. Thus, many changes and modifications may be made to the subject technology, by one having ordinary skill in the art, without departing from the scope of the subject technology.


A phrase such as “an aspect” does not imply that such aspect is essential to the subject technology or that such aspect applies to all configurations of the subject technology. A disclosure relating to an aspect may apply to all configurations, or one or more configurations. An aspect may provide one or more examples of the disclosure. A phrase such as “an aspect” may refer to one or more aspects and vice versa. A phrase such as “an embodiment” does not imply that such embodiment is essential to the subject technology or that such embodiment applies to all configurations of the subject technology. A disclosure relating to an embodiment may apply to all embodiments, or one or more embodiments. An embodiment may provide one or more examples of the disclosure. A phrase such “an embodiment” may refer to one or more embodiments and vice versa. A phrase such as “a configuration” does not imply that such configuration is essential to the subject technology or that such configuration applies to all configurations of the subject technology. A disclosure relating to a configuration may apply to all configurations, or one or more configurations. A configuration may provide one or more examples of the disclosure. A phrase such as “a configuration” may refer to one or more configurations and vice versa.


It is understood that the specific order or hierarchy of steps in the processes disclosed is an illustration of exemplifying approaches. Based upon design preferences, it is understood that the specific order or hierarchy of steps in the processes may be rearranged. Some of the steps may be performed simultaneously. The accompanying method claims present elements of the various steps in a sample order, and are not meant to be limited to the specific order or hierarchy presented.


Furthermore, to the extent that the term “include,” “have,” or the like is used in the description or the claims, such term is intended to be inclusive in a manner similar to the term “comprise” as “comprise” is interpreted when employed as a transitional word in a claim.


A reference to an element in the singular is not intended to mean “one and only one” unless specifically stated, but rather “one or more.” The term “some” refers to one or more. All structural and functional equivalents to the elements of the various configurations described throughout this disclosure that are known or later come to be known to those of ordinary skill in the art are expressly incorporated herein by reference and intended to be encompassed by the subject technology. Moreover, nothing disclosed herein is intended to be dedicated to the public regardless of whether such disclosure is explicitly recited in the above description.


While certain aspects and embodiments of the subject technology have been described, these have been presented by way of example only, and are not intended to limit the scope of the subject technology. Indeed, the novel methods and systems described herein may be embodied in a variety of other forms without departing from the spirit thereof. The accompanying claims and their equivalents are intended to cover such forms or modifications as would fall within the scope and spirit of the subject technology.

Claims
  • 1. An implant comprising: a proximal end portion defining a lumen;an expansion member having (i) a proximal end located distal to the proximal end portion and (ii) a distal end located proximal to a distal region of a delivery wire, the distal region being distal to the proximal end portion, the expansion member being biased to expand distally from a non-relaxed state toward a relaxed state and thereby move the distal region of the delivery wire distally away from the proximal end portion; anda hub at the proximal end portion and in apposition with the proximal end of the expansion member,wherein at least a portion of the delivery wire extends entirely through the lumen.
  • 2. The implant of claim 1, wherein the expansion member comprises a spring.
  • 3. The implant of claim 1, wherein a distal cross-sectional dimension of the distal region is greater than a lumen cross-sectional dimension of the lumen.
  • 4. The implant of claim 1, wherein the delivery wire comprises a detachment zone proximal to the proximal end portion.
  • 5. The implant of claim 4, wherein a distal cross-sectional dimension of the distal region is greater than a proximal cross-sectional dimension of the detachment zone.
  • 6. The implant of claim 4, further comprising a coating layer that electrically insulates portions of the delivery wire in apposition to the detachment zone.
  • 7. The implant of claim 1, wherein the expansion member is disposed around the distal region of the delivery wire.
  • 8. The implant of claim 1, wherein the expansion member is axially movable from the non-relaxed state to the relaxed state.
  • 9. The implant of claim 1, wherein the proximal end of the expansion member is in contact with a distal end portion of the hub and the distal end of the expansion member is in contact with the distal region of the delivery wire.
  • 10. A system comprising: an implant having a proximal end portion;a delivery wire having (i) a detachment zone proximal to the proximal end portion, and (ii) a distal region distal to the proximal end portion;an expansion member having (i) a proximal end located distal to the proximal end portion and (ii) a distal end located proximal to the distal region of the delivery wire, the expansion member being biased to expand distally from a non-relaxed state toward a relaxed state and thereby move the distal region of the delivery wire distally away from the proximal end portion;a hub at the proximal end portion of the implant and in apposition to the proximal end of the expansion member; anda catheter, wherein at least a portion of the delivery wire is within the catheter.
  • 11. The system of claim 10, wherein the expansion member comprises a spring disposed at least partially around the distal region of the delivery wire.
  • 12. The system of claim 10, wherein the proximal end portion defines a lumen, and at least a portion of the delivery wire extends entirely through the lumen.
  • 13. The system of claim 12, wherein a distal cross-sectional dimension of the distal region is greater than a lumen cross-sectional dimension of the lumen.
  • 14. The system of claim 10, wherein a distal cross-sectional dimension of the distal region is greater than a proximal cross-sectional dimension of the detachment zone.
  • 15. The system of claim 10, further comprising a proximal insulating layer that electrically insulates a portion of the delivery wire proximal of the detachment zone, and a distal insulating layer that electrically insulates a portion of the delivery wire distal of the detachment zone.
  • 16. A method of delivering an implant, the method comprising: positioning the implant at a target location within a patient, the implant being attached to a delivery wire having (i) a proximal region, (ii) a detachment zone proximal to a proximal end portion of the implant, and (iii) a distal region distal to the proximal end portion, the implant having (i) an expansion member having a proximal end located distal to the proximal end portion and a distal end located proximal to the distal region of the delivery wire, and (ii) a hub at the proximal end portion of the implant and in apposition to the proximal end of the expansion member, the expansion member being biased to expand distally from a non-relaxed state toward a relaxed state and thereby move the distal region of the delivery wire distally away from the proximal end portion; andseparating the distal region from the proximal region at the detachment zone, thereby allowing the distal region to advance distally away from the proximal end portion.
  • 17. The method of claim 16, wherein separating the implant distal region comprises electrolytically corroding a portion of the delivery wire.
  • 18. The method of claim 16, wherein positioning the implant comprises applying a distally directed force to the proximal end portion and a proximally directed force to the delivery wire.
  • 19. The method of claim 18, wherein applying the distally directed force to the proximal end portion comprises pushing the proximal end portion with a catheter.
  • 20. The method of claim 19, wherein at least a portion of the delivery wire is within the catheter during the separating.
  • 21. The method of claim 16, wherein the distal region advances such that the detachment zone and the distal region of the delivery wire are entirely distal to a proximal end of the proximal end portion.
CROSS REFERENCE TO RELATED APPLICATIONS

This application claims the benefit of priority of U.S. Provisional Patent Application No. 62/354,968 filed Jun. 27, 2016, which is hereby incorporated by reference in its entirety.

US Referenced Citations (286)
Number Name Date Kind
5108407 Geremia et al. Apr 1992 A
5122136 Guglielmi et al. Jun 1992 A
5250071 Palermo Oct 1993 A
5354295 Guglielmi et al. Oct 1994 A
5370653 Cragg Dec 1994 A
5423829 Pham et al. Jun 1995 A
5509411 Littmann et al. Apr 1996 A
5522836 Palermo Jun 1996 A
5540680 Guqlielmi et al. Jul 1996 A
5624449 Pham et al. Apr 1997 A
5658308 Snyder Aug 1997 A
5669931 Kupiecki et al. Sep 1997 A
5690667 Gia Nov 1997 A
5733329 Wallace et al. Mar 1998 A
5743905 Eder et al. Apr 1998 A
5749894 Engelson May 1998 A
5766629 Cho et al. Jun 1998 A
5800455 Palermo et al. Sep 1998 A
5851206 Guglielmi et al. Dec 1998 A
5853418 Ken et al. Dec 1998 A
5855578 Guglielmi et al. Jan 1999 A
5891128 Gia et al. Apr 1999 A
5895385 Guqlielmi et al. Apr 1999 A
5910154 Tsugita Jun 1999 A
5916235 Guglielmi Jun 1999 A
5919187 Guqlielmi et al. Jul 1999 A
5925037 Guglielmi et al. Jul 1999 A
5925059 Palermo et al. Jul 1999 A
5928226 Guqlielmi et al. Jul 1999 A
5935145 Villar et al. Aug 1999 A
5941888 Wallace et al. Aug 1999 A
5944114 Guglielmi et al. Aug 1999 A
5947962 Guglielmi et al. Sep 1999 A
5947963 Guqlielmi Sep 1999 A
5951599 McCrory Sep 1999 A
5964797 Ho Oct 1999 A
5976126 Guglielmi Nov 1999 A
5984929 Bashiri et al. Nov 1999 A
6010498 Guqlielmi Jan 2000 A
6013084 Ken et al. Jan 2000 A
6059779 Mills May 2000 A
6063070 Eder May 2000 A
6063104 Villar et al. May 2000 A
6066133 Guglielmi et al. May 2000 A
6077260 Wheelock et al. Jun 2000 A
6083220 Guglielmi et al. Jul 2000 A
6123714 Gia et al. Sep 2000 A
6136015 Kurz et al. Oct 2000 A
6146373 Cragg et al. Nov 2000 A
6156061 Wallace et al. Dec 2000 A
6165178 Bashiri et al. Dec 2000 A
6168592 Kupiecki et al. Jan 2001 B1
6168615 Ken et al. Jan 2001 B1
6168618 Frantzen Jan 2001 B1
6193728 Ken et al. Feb 2001 B1
6238403 Greene, Jr. et al. May 2001 B1
6241691 Ferrera et al. Jun 2001 B1
6280457 Wallace et al. Aug 2001 B1
6296622 Kurz et al. Oct 2001 B1
6299619 Greene, Jr. et al. Oct 2001 B1
6306153 Kurz et al. Oct 2001 B1
6309367 Boock Oct 2001 B1
6371972 Wallace et al. Apr 2002 B1
6409721 Wheelock et al. Jun 2002 B1
6416373 Kolb et al. Jul 2002 B1
6425893 GuQlielmi Jul 2002 B1
6425914 Wallace et al. Jul 2002 B1
6468266 Bashiri et al. Oct 2002 B1
6468301 Amplatz et al. Oct 2002 B1
6478773 Gandhi et al. Nov 2002 B1
6485524 Strecker Nov 2002 B2
6486266 Amano et al. Nov 2002 B2
6511468 Craaa et al. Jan 2003 B1
6533801 Wallace et al. Mar 2003 B2
6558367 Craaa et al. May 2003 B1
6589230 Gia et al. Jul 2003 B2
6589236 Wheelock et al. Jul 2003 B2
6602261 Greene, Jr. et al. Aug 2003 B2
6605101 Schaefer et al. Aug 2003 B1
6620152 Guqlielmi Sep 2003 B2
6623493 Wallace et al. Sep 2003 B2
6723112 Ho et al. Apr 2004 B2
6743251 Eder Jun 2004 B1
6835185 Ramzipoor et al. Dec 2004 B2
6878384 Cruise et al. Apr 2005 B2
6905503 Gifford, III et al. Jun 2005 B2
6936055 Ken et al. Aug 2005 B1
6953473 Porter Oct 2005 B2
6964657 Craaa et al. Nov 2005 B2
6966892 Gandhi et al. Nov 2005 B2
7014645 Greene, Jr. et al. Mar 2006 B2
7083567 Mawad Aug 2006 B2
7094249 Broome Aug 2006 B1
7128736 Abrams et al. Oct 2006 B1
7166122 Aqanon et al. Jan 2007 B2
7169172 Levine et al. Jan 2007 B2
7198613 Gandhi et al. Apr 2007 B2
7229461 Chin et al. Jun 2007 B2
7238194 Monstadt et al. Jul 2007 B2
7255707 Ramzipoor et al. Aug 2007 B2
7300458 Henkes et al. Nov 2007 B2
7323000 Monstdt et al. Jan 2008 B2
7331974 Schaefer et al. Feb 2008 B2
7485122 Teoh Feb 2009 B2
7524322 Monstdt et al. Apr 2009 B2
7601160 Richter Oct 2009 B2
7608089 Wallace et al. Oct 2009 B2
RE41029 Guglielmi et al. Dec 2009 E
7651513 Teoh et al. Jan 2010 B2
7695484 Wallace et al. Apr 2010 B2
7879064 Monstadt et al. Feb 2011 B2
7896899 Patterson et al. Mar 2011 B2
7938845 Aganon et al. May 2011 B2
RE42625 Guglielmi Aug 2011 E
8002789 Ramzipoor et al. Aug 2011 B2
RE42756 Guqlielmi et al. Sep 2011 E
8016869 Nikolchev Sep 2011 B2
8021416 Abrams Sep 2011 B2
8043326 Hancock et al. Oct 2011 B2
8048104 Monstadt et al. Nov 2011 B2
RE43311 Wallace et al. Apr 2012 E
8157855 Eidenschink et al. Apr 2012 B2
8202292 Kellett Jun 2012 B2
8221396 Dehnad et al. Jul 2012 B2
8221483 Ford et al. Jul 2012 B2
8273116 Licata et al. Sep 2012 B2
8298256 Gandhi et al. Oct 2012 B2
8328860 Strauss et al. Dec 2012 B2
8372110 Monstadt et al. Feb 2013 B2
8398671 Chen et al. Mar 2013 B2
8425541 Masters et al. Apr 2013 B2
8470013 Duggal et al. Jun 2013 B2
8480701 Monstadt Jul 2013 B2
8562667 Cox Oct 2013 B2
8597321 Monstadt et al. Dec 2013 B2
8632584 Henkes et al. Jan 2014 B2
8641746 Andreas et al. Feb 2014 B2
8641777 Strauss et al. Feb 2014 B2
8652163 Padilla et al. Feb 2014 B2
8657870 Turovskiv et al. Feb 2014 B2
8715312 Burke et al. May 2014 B2
8715317 Janardhan et al. May 2014 B1
8721625 Klint May 2014 B2
8728142 Gandhi et al. May 2014 B2
8777978 Strauss et al. Jul 2014 B2
8777979 Shrivastava et al. Jul 2014 B2
8795320 Strauss et al. Aug 2014 B2
8795321 Strauss et al. Aug 2014 B2
8801747 Strauss et al. Aug 2014 B2
8845676 Monstadt et al. Sep 2014 B2
8864790 Strauss et al. Oct 2014 B2
8870909 Cox Oct 2014 B2
8876863 Eskridqe Nov 2014 B2
8900285 Licata Dec 2014 B2
8906057 Connor et al. Dec 2014 B2
8915950 Cam et al. Dec 2014 B2
8926681 Levv et al. Jan 2015 B2
8932317 Marks et al. Jan 2015 B2
8940011 Teoh et al. Jan 2015 B2
8974509 Licata Mar 2015 B2
8974513 Ford et al. Mar 2015 B2
8992563 Chen Mar 2015 B2
8998926 Pomeranz Apr 2015 B2
9039749 Shrivastava et al. May 2015 B2
9050095 Monstadt et al. Jun 2015 B2
9055948 Jaeqer et al. Jun 2015 B2
9211202 Strother et al. Dec 2015 B2
9486224 Riina et al. Nov 2016 B2
9833309 Levi et al. Dec 2017 B2
9844380 Furey Dec 2017 B2
9907684 Connor et al. Mar 2018 B2
9962146 Hebert et al. May 2018 B2
10028745 Morsi Jul 2018 B2
20010000797 Mazzocchi May 2001 A1
20010001835 Greene et al. May 2001 A1
20020151883 Guqlielmi Oct 2002 A1
20020151927 Douk Oct 2002 A1
20030014073 Bashiri et al. Jan 2003 A1
20030018294 Cox Jan 2003 A1
20030028209 Teoh et al. Feb 2003 A1
20030040733 Cragg et al. Feb 2003 A1
20030040772 Hyodoh et al. Feb 2003 A1
20030060833 Carrison et al. Mar 2003 A1
20030176857 Lee Sep 2003 A1
20030181927 Wallace Sep 2003 A1
20030212426 Olson et al. Nov 2003 A1
20030225365 Greff et al. Dec 2003 A1
20040002731 Aqanon et al. Jan 2004 A1
20040002733 Teoh Jan 2004 A1
20040225279 Ravmond Nov 2004 A1
20040236344 Monstadt et al. Nov 2004 A1
20050079196 Henkes et al. Apr 2005 A1
20050267511 Marks et al. Dec 2005 A1
20060036281 Patterson et al. Feb 2006 A1
20060100602 Klint May 2006 A1
20060135986 Wallace et al. Jun 2006 A1
20060155323 Porter et al. Jul 2006 A1
20060200234 Hines Sep 2006 A1
20060206199 Churchwell et al. Sep 2006 A1
20060271097 Ramzipoor et al. Nov 2006 A1
20070073334 Ramzipoor Mar 2007 A1
20070100426 Rudakov et al. May 2007 A1
20070175536 Monetti et al. Aug 2007 A1
20070191924 Rudakov Aug 2007 A1
20080045922 Cragg et al. Feb 2008 A1
20080051803 Monjtadt et al. Feb 2008 A1
20080103585 Monstadt et al. May 2008 A1
20080125855 Henkes et al. May 2008 A1
20080221666 Licata et al. Sep 2008 A1
20080228215 Strauss et al. Sep 2008 A1
20080228216 Strauss et al. Sep 2008 A1
20080319532 Monstadt et al. Dec 2008 A1
20090143786 Bashiri et al. Jun 2009 A1
20090227976 Calabria Sep 2009 A1
20090254111 Monstadt et al. Oct 2009 A1
20100023105 Levv et al. Jan 2010 A1
20100030200 Strauss et al. Feb 2010 A1
20100049165 Sutherland et al. Feb 2010 A1
20100063572 Teoh et al. Mar 2010 A1
20100076479 Monstadt Mar 2010 A1
20100144895 Porter Jun 2010 A1
20100256666 Chen et al. Oct 2010 A1
20100268204 Tieu et al. Oct 2010 A1
20100331948 Turovskiy et al. Dec 2010 A1
20110098814 Monstadt et al. Apr 2011 A1
20110106128 Chen May 2011 A1
20110118768 Tran et al. May 2011 A1
20110118777 Patterson et al. May 2011 A1
20110137405 Wilson et al. Jun 2011 A1
20110184453 Levy et al. Jul 2011 A1
20120010648 Monstadt et al. Jan 2012 A1
20120209310 Chen Aug 2012 A1
20120271344 Ford et al. Oct 2012 A1
20120316632 Gao Dec 2012 A1
20130138198 Aporta et al. May 2013 A1
20130184743 Chen et al. Jul 2013 A1
20130211492 Schneider et al. Aug 2013 A1
20130274866 Cox et al. Oct 2013 A1
20140005651 Eskridqe Jan 2014 A1
20140012307 Franano et al. Jan 2014 A1
20140039535 Eskuri Feb 2014 A1
20140058420 Hannes et al. Feb 2014 A1
20140135818 Gandhi et al. May 2014 A1
20140142608 Eskridge et al. May 2014 A1
20140148843 Strauss et al. May 2014 A1
20140163604 Monstadt Jun 2014 A1
20140236217 Gandhi et al. Aug 2014 A1
20140277092 Teoh et al. Sep 2014 A1
20140277094 Chen et al. Sep 2014 A1
20140288633 Burke et al. Sep 2014 A1
20140316012 Freyman et al. Oct 2014 A1
20140371734 Truckai Dec 2014 A1
20140371839 Henkes et al. Dec 2014 A1
20150005804 Franano et al. Jan 2015 A1
20150057700 Chen et al. Feb 2015 A1
20150066073 Ma Mar 2015 A1
20150105817 Marchand et al. Apr 2015 A1
20150133990 Davidson May 2015 A1
20150142042 Cox May 2015 A1
20150150563 Marchand et al. Jun 2015 A1
20150157331 Levy et al. Jun 2015 A1
20150164665 Cam et al. Jun 2015 A1
20150173771 Marks et al. Jun 2015 A1
20150216684 Enzmann et al. Aug 2015 A1
20150250628 Monstadt et al. Sep 2015 A1
20150313737 Tippett et al. Nov 2015 A1
20150327843 Garrison Nov 2015 A1
20160066921 Seifert et al. Mar 2016 A1
20160135984 Rudakov et al. May 2016 A1
20160206320 Connor Jul 2016 A1
20160206321 Connor Jul 2016 A1
20170150971 Hines Jun 2017 A1
20170156903 Shobayashi Jun 2017 A1
20170189035 Porter Jul 2017 A1
20170266023 Thomas Sep 2017 A1
20170340333 Badruddin et al. Nov 2017 A1
20170367708 Mayer et al. Dec 2017 A1
20180028190 Ozasa Feb 2018 A1
20180049859 Stoppenhagen et al. Feb 2018 A1
20180125686 Lu May 2018 A1
20180140305 Connor May 2018 A1
20180161185 Kresslein et al. Jun 2018 A1
20180193025 Walzman Jul 2018 A1
20180193026 Yang et al. Jul 2018 A1
20180206852 Moeller Jul 2018 A1
20190053811 Garza et al. Feb 2019 A1
Foreign Referenced Citations (9)
Number Date Country
4445715 Jun 1996 DE
1884208 Feb 2008 EP
2668914 Dec 2013 EP
2982316 Feb 2016 EP
2004075736 Sep 2004 WO
2011066962 Jun 2011 WO
WO-2014078286 May 2014 WO
2017074411 May 2017 WO
2018051187 Mar 2018 WO
Non-Patent Literature Citations (1)
Entry
International Search Report and Written Opinion dated Aug. 4, 2017, International Patent Application No. PCT/US2017/036699, 16 pages.
Related Publications (1)
Number Date Country
20170367704 A1 Dec 2017 US
Provisional Applications (1)
Number Date Country
62354968 Jun 2016 US